Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.1.399

Bufalin, a Traditional Oriental Medicine, Induces Apoptosis in Human Cancer Cells  

Takai, Noriyuki (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine)
Kira, Naoko (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine)
Ishii, Terukazu (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine)
Yoshida, Toshie (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine)
Nishida, Masakazu (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine)
Nishida, Yoshihiro (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine)
Nasu, Kaei (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine)
Narahara, Hisashi (Department of Obstetrics and Gynecology, Oita University Faculty of Medicine)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.1, 2012 , pp. 399-402 More about this Journal
Abstract
Bufalin is a traditional oriental medicines which induces apoptosis in some lines of human tumor cells. It constitutes the major digoxin-like immunoreactive component of Chan Su, obtained from the skin and parotid venom glands of toads. Bufalin is cardioactive C-24 steroids that exhibits a variety of biological activities, such as cardiotonic, anaesthetic, blood pressure stimulatory, respiratory and antineoplastic effects. In terms of its anti-tumor activity, bufalin has been demonstrated to inhibit the growth of tumors, such as endometrial and ovarian cancers. This commentary introduces biologic and therapeutic effects of bufalin in treating some cancers. The compound is able to mediate inhibition of cell growth, cell cycle arrest, apoptosis, and expression of genes related to the malignant phenotype in human cancer cells.
Keywords
Traditional oriental medicines; bufalin; cell cycle; apoptosis; cancer;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Xie CM, Chan WY, Yu S, et al (2011). Bufalin induces autophagy-mediated cell death in human colon cancer cells through reactive oxygen species generation and JNK activation. Free Radical Biol Med, 51, 1365-75.   DOI
2 Yeh J-Y, Huang WJ, Kan S-F, et al (2003). Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells. Prostate, 54, 112-24.   DOI
3 Yu CH, Kan SF, Pu HF, et al (2008). Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells. Cancer Sci, 99, 2467-76.   DOI
4 Zhang LS, Nakaya K, Yoshida T, et al (1991). Bufalin as a potent inducer of differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun, 178, 686-93.   DOI
5 Kawazoe N, Watabe M, Masuda Y, et al (1999). Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells. Oncogene, 18, 2413-21.   DOI
6 Krenn L, Kopp B (1998). Bufadienolides from animal and plant sources. Phytochemistry, 48, 1-29.   DOI
7 Morishita S, Shoji M, Oguni Y (1992). Pharmacological actions of 'Kyusin', a drug containing toad venom: cardiotonic and arrhythmogenic effects. Am J Chin Med, 20, 245-6.   DOI
8 Li D, Qu X, Hou K, et al (2009). PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells. Anticancer Drugs, 20, 59-64.   DOI
9 Masuda Y, Kawazoe N, Nakajo S, et al (1995). Bufalin induces apoptosis and influences the expression of apoptosis-related genes in human leukemia cells. Leuk Res, 19, 549-56.   DOI
10 Meng Z, Yang P, Shen Y, et al (2009). Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer. Cancer, 115, 5309-18.   DOI
11 Numazawa S, Shinoki M, Ito H, et al (1994). Involvement of Na+,K+-ATPase inhibition in K562 cell differentiation induced by bufalin. J Cell Physiol, 160, 113-20.   DOI
12 Panesar NS (1992). Bufalin and unidentified substance(s) in traditional Chinese medicine cross-react in commercial digoxin assay. Clin Chem, 38, 2155-6.
13 Song H, Guo T, Bi K, et al (2000). Determination of resibufogenin and cinobufagin in heart-protecting musk pill by HPLC. Biomed Chromatogr, 14, 130-2.   DOI
14 Takai N, Ueda T, Nishida M, et al (2008). Bufalin induces growth inhibition, cell cycle arrest and apoptosis in human endometrial and ovarian cancer cells. Int J Mol Med, 21, 637-43.
15 Watabe M, Ito K, Masuda Y, et al. (1998). Activation of AP-1 is required for bufalin-induced apoptosis in human leukemia U937 cells. Oncogene, 16, 779-87.   DOI
16 Hong SH, Choi YH (2012). Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells. Oncol Rep, 27, 114-20.
17 Chueh FS, Chen YY, Huang AC, et al (2011). Bufalininhibited migration and invasion in human osteosarcoma U-2 OS cells is carried out by suppression of the matrix metalloproteinase-2, ERK, and JNK signaling pathways. Environ Toxicol, in press.
18 Dong Y, Yin S, Li J, et al (2011). Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway. Apoptosis, 16, 394-403.   DOI
19 Han KQ, Huang G, Gu W, et al (2007). Anti-tumor activities and apoptosis-regulated mechanisms of bufalin on the orthotopic transplantation tumor model of human hepatocellular carcinoma in nude mice. World J Gastroenterol, 13, 3374-9.   DOI
20 Hong Z, Chen K, Yeung HW (1992). Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, Liu Shen Wan, by liquid chromatography. J Pharm Pharmacol, 44, 1023-6.   DOI
21 Jiang Y, Zhang Y, Luan J, et al (2010). Effects of bufalin on the proliferation of human lung cancer cells and its molecular mechanisms of action. Cytotechnology, 62, 573-83.   DOI
22 Jing Y, Watabe M, Hashimoto S, et al (1994a). Cell cycle arrest and protein kinase modulating effect of bufalin on human leukemia ML1 cells. Anticancer Res, 14, 1193-8.
23 Jing Y, Ohizumi H, Kawazoe N, et al (1994b). Selective inhibitory effect of bufalin on growth of human tumor cells in vitro: association with the induction of apoptosis in leukemia HL-60 cells. Jpn J Cancer Res, 85, 645-51.   DOI